Clinical Trial Update: Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study [Phase 2]

View source ↗

Summary

Phase 2 study (VERTPAC-02) evaluating ultrasound-guided verteporfin photodynamic therapy for unresectable solid pancreatic tumors or advanced pancreatic cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Visudyne (verteporfin)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-30